HPHTF(HPHTF)
HPHTF
No analyst ratings available
No analyst price targets available for HPHTF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $230.50B | $244.97B | $261.87B | $277.92B | $294.27B |
| Low | $222.73B | $234.11B | $251.61B | $267.03B | $282.74B |
| High | $240.14B | $254.51B | $272.43B | $289.13B | $306.14B |
| EBITDA Avg | $66.09B | $70.24B | $75.09B | $79.69B | $84.38B |
| Low | $63.86B | $67.13B | $72.15B | $76.57B | $81.07B |
| High | $68.86B | $72.98B | $78.12B | $82.90B | $87.78B |
| EBIT Avg | $47.40B | $50.37B | $53.85B | $57.15B | $60.51B |
| Low | $45.80B | $48.14B | $51.74B | $54.91B | $58.14B |
| High | $49.38B | $52.34B | $56.02B | $59.46B | $62.95B |
| Net Income Avg | $17.02B | $19.71B | $23.75B | $26.88B | $29.23B |
| Low | $16.15B | $18.70B | $22.54B | $25.51B | $27.74B |
| High | $17.91B | $20.74B | $24.99B | $28.29B | $30.77B |
| EPS Avg | $56.70 | $65.65 | $79.11 | $89.54 | $97.39 |
| Low | $53.81 | $62.31 | $75.08 | $84.98 | $92.42 |
| High | $59.68 | $69.09 | $83.26 | $94.24 | $102.49 |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 | 3 / 1 | 4 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $63.76B | $58.00B | $61.13B | $59.59B | $63.92B |
| Low | $62.39B | $56.75B | $59.82B | $58.31B | $62.55B |
| High | $66.49B | $60.49B | $63.75B | $62.14B | $66.66B |
| EBITDA Avg | $18.28B | $16.63B | $17.53B | $17.09B | $18.33B |
| Low | $17.89B | $16.27B | $17.15B | $16.72B | $17.93B |
| High | $19.07B | $17.34B | $18.28B | $17.82B | $19.11B |
| EBIT Avg | $13.11B | $11.93B | $12.57B | $12.25B | $13.14B |
| Low | $12.83B | $11.67B | $12.30B | $11.99B | $12.86B |
| High | $13.67B | $12.44B | $13.11B | $12.78B | $13.71B |
| Net Income Avg | — | — | — | — | — |
| Low | — | — | — | — | — |
| High | — | — | — | — | — |
| EPS Avg | — | — | — | — | — |
| Low | — | — | — | — | — |
| High | — | — | — | — | — |
| Analysts (Rev / EPS) | 5 / — | 2 / — | 2 / — | 2 / — | 2 / — |